$IMA
ImageneBio, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$4.89
▼-2.59%-$0.130
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateImageneBio, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is IMA down today? It is at $4.89 (-2.59%). See the catalyst behind the move, real-time alerts the moment IMA spikes, and full due diligence on IMA — key stats, earnings, dilution and insider activity. Free.
Be first to know when $IMA makes an unusual move. Create a free account to track $IMA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on IMA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Across every filing on file, supply equal to 86.4% of the tradeable float is in play - 53.1% has already been sold, and 33.3% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
Recent share offering + active shelf on file — the company raised capital and can raise more
2,508,337 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Grant-Huerta Yanina Officer | Acquired (grant/award) | +104K 0.9% of company | n/a | 104K | n/a | Aug 14, 26 |
Yarema Kristin Officer | Acquired (grant/award) | +255K 2.2% of company | added 100% | 494K | n/a | Aug 14, 26 |
Yarema Kristin Officer | Acquired (grant/award) | +115K 1.0% of company | added 93% | 239K | n/a | Jul 25, 26 |
Yarema Kristin Officer | Other | 38K 0.3% of company | added 45% | 124K | n/a | Jul 25, 26 |
Lally Robert B Officer | Sold (automatic/other) | -2K 0.01% of company | sold 2.7% | 56K | $8K at $5.34 | Jul 17, 26 |
Lally Robert B Officer | Sold (automatic/other) | -2K 0.01% of company | sold 2.8% | 57K | $9K at $5.50 | Jul 16, 26 |
Yarema Kristin Officer | Acquired (grant/award) | +85K 0.8% of company | n/a | 85K | n/a | Mar 16, 26 |
Butler Erin Officer | Acquired (grant/award) | +23K 0.2% of company | added 100% | 26K | n/a | Dec 30, 25 |
Slattery Joseph P Director | Bought (open market) | +16K 0.1% of company | n/a | 16K | $96K at $5.99 | Dec 24, 25 |
Marango Jotin Officer | Acquired (grant/award) | +16K 0.1% of company | n/a | 16K | n/a | Jul 28, 25 |
Marango Jotin Officer | Sold (automatic/other) | -5K 0.04% of company | sold 29% | 11K | $79K at $17.16 | Jul 28, 25 |
Butler Erin Officer | Acquired (grant/award) | +3K 0.03% of company | n/a | 3K | n/a | Jul 25, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on IMA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for IMA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
IMA last traded at $4.89, down 2.59% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
ImageneBio, Inc. Common Stock (IMA) is next expected to report earnings on Wednesday, November 11, 2026, about 52 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The IMA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged IMA 0 times in the last 30 days.
IMA (ImageneBio, Inc. Common Stock) trades on XNAS, with a market cap of about $56M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge IMA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$IMA discussion
Sign in to ask a question or join the discussion.